BioStorage Technologies Launches INTEGRITY Study to Measure Effect of Time, Temperature and Preparation Methods on DNA and RNA Samples
INDIANAPOLIS, Aug. 14, 2013 /PRNewswire/ -- BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, announced today that the company has initiated the INTEGRITY Study. The 24-month study will analyze human whole blood samples to measure the impact on the long-term integrity of DNA and RNA when various preparation methods, storage temperatures and storage times are applied.
Conducted at BioStorage Technologies' global biorepository in Indianapolis, the study will compare fresh samples, frozen pre-extracted samples and extracted nucleic acids, which require freeze/ thaw cycles for processing. Various storage temperatures and aliquoting strategies will be evaluated and reported over the length of the study.
"The INTEGRITY study has a unique comprehensive study design that will help provide the industry with recommended best practices and techniques to support the optimal preservation of DNA and RNA samples for prospective and retrospective research studies," said Lori Ball, COO, BioStorage Technologies. "Our goal is to determine the effects of various preparation methods on whole blood samples for nucleic acid extraction and the optimal length of time and best temperature to store samples for future research."
Existing research suggests that inexact sample preparation and storage methods may affect the results or analysis of biological studies and can lead to sample loss, reprocessing or complicated data interpretation. However, to date, most studies have been designed to analyze the impact of a single temperature and have not been focused on the long-term effects of various temperatures, methods of freeze-thaw and storage time on DNA and RNA integrity within a single study.
"As an advocate for advancing the global biobanking industry, BioStorage Technologies has become an informational resource for best practices at all stages of the sample management life-cycle, and with the INTEGRITY Study we hope to provide data-driven research in a comprehensive single-study format that has never before been done," said Greg Swanberg, CEO, BioStorage Technologies.
For more information on the INTEGRITY Study, visit www.biostorage.com.
About BioStorage Technologies, Inc.:
BioStorage Technologies, Inc. is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering flexible onsite, offsite and hybrid models for the smartsourcing of research assets, BioStorage Technologies provides a complete life-cycle of sample management solutions. With an expert team of global sample consultants, industry-leading temperature-controlled storage facilities, and state-of-the-art virtual sample management and bioprocessing solutions, the company supports its customers in maximizing opportunities, minimizing risk and reducing costs. BioStorage Technologies, Inc. is a privately held, global corporation. For more information, visit www.biostorage.com or call +1 866 697 2675 for North America, +49 6155 898 1011 for Europe or +65 31576199 for Asia-Pacific.
Miller Brooks, Inc.
SOURCE BioStorage Technologies, Inc.